Fabry Patients Ask HHS to Issue Open License for Fabrazyme

Drug Industry Daily
A A
Three people with Fabry disease are asking the HHS to issue an open license that would allow other companies to manufacture Genzyme’s Fabrazyme amid a shortage of the treatment.

To View This Article:

Login

Subscribe To Drug Industry Daily